BioLineRx (BLRX -21%) is down out of the gate this morning as investors appear disappointed with topline results from a Phase 2a clinical trial evaluating lead candidate BL-8040 plus Merck's (MRK -0.1%) Keytruda...查看全文
忘江2018-10-19 23:00
$BioLineRx Ltd. - American Depositary Shares(BLRX)$
看来赌数据真是不能赌啊。
下面摘自半年报。
Expected significant milestones in next 18 months:
Top-line results in immuno-oncology Phase 2a COMBAT study in pancreatic cancer for BL-8040 in combination with KEY...查看全文
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001889 Act: 34 Size: 595 KB 网页链接
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001842 Act: 34 Size: 1 MB 网页链接
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001827 Act: 34 Size: 599 KB 网页链接
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001769 Act: 34 Size: 588 KB 网页链接
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001582 Act: 34 Size: 607 KB 网页链接
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001347 Act: 34 Size: 612 KB 网页链接
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001285 Act: 34 Size: 595 KB 网页链接
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001174 Act: 34 Size: 1 MB 网页链接
$BioLineRx(BLRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001178913-24-001173 Act: 33 Size: 733 KB 网页链接
$BioLineRx(BLRX)$ 20-F/A [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001178913-24-001095 Act: 34 Size: 14 MB 网页链接